| Cancer | Chr | Position | Mutation Type | dbSNP | Protein-change | Allele Freq | RBD |
|---|---|---|---|---|---|---|---|
| BLCA | |||||||
| BRCA | |||||||
| CESC | |||||||
| CESC | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| GBM | |||||||
| GBM | |||||||
| GBM | |||||||
| HNSC | |||||||
| HNSC | |||||||
| LIHC | |||||||
| LIHC | |||||||
| LIHC | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUSC | |||||||
| LUSC | |||||||
| LUSC | |||||||
| LUSC | |||||||
| LUSC | |||||||
| OV | |||||||
| OV | |||||||
| PAAD | |||||||
| READ | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC |
| Cancer | Type | Freq | Q-value |
|---|---|---|---|
| BRCA | |||
| CHOL | |||
| ESCA | |||
| LAML | |||
| LGG | |||
| LIHC | |||
| PRAD | |||
| TGCT | |||
| THCA | |||
| THYM | |||
| UCS |
| Cancer | P-value | Q-value |
|---|---|---|
| THYM | ||
| SARC | ||
| ACC | ||
| SKCM | ||
| LUSC | ||
| COAD | ||
| BLCA | ||
| UCEC | ||
| LGG | ||
| LUAD |
| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000373587 | NR5A1-201 | 768 | - | ENSP00000362689 | 245 (aa) | - | Q5T6F7 |
| ENST00000455734 | NR5A1-203 | 826 | - | ENSP00000393245 | 177 (aa) | - | Q5T6F6 |
| ENST00000620110 | NR5A1-204 | 2975 | - | ENSP00000483309 | 421 (aa) | - | F1DAM0 |
| ENST00000373588 | NR5A1-202 | 3104 | - | ENSP00000362690 | 461 (aa) | - | Q13285 |
| ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000136931 | rs117724125 | 9 | 124489501 | T | Ankle injury | 28957384 | 1.6205 | EFO_1002021 | |
| ENSG00000136931 | rs2297605 | 9 | 124493169 | ? | Menarche (age at onset) | 30595370 | EFO_0004703 | ||
| ENSG00000136931 | rs2297605 | 9 | 124493169 | A | Alcohol consumption (drinks per week) (MTAG) | 30643251 | [0.005-0.0104] unit increase | 0.00768614 | EFO_0007878 |
| ENSG00000136931 | rs4838192 | 9 | 124488222 | T | Chronotype | 30696823 | [0.0058-0.0124] unit increase | 0.00912265 | EFO_0008328 |

| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0000976 | transcription regulatory region sequence-specific DNA binding | 21873635. | IBA | Function |
| GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 23610160. | IDA | Function |
| GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | - | ISS | Function |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 21412441. | IDA | Function |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | - | ISA | Function |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 19274049. | ISM | Function |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 19274049. | NAS | Function |
| GO:0001553 | luteinization | - | IEA | Process |
| GO:0003677 | DNA binding | 10567391. | IDA | Function |
| GO:0003682 | chromatin binding | 21873635. | IBA | Function |
| GO:0003682 | chromatin binding | - | ISS | Function |
| GO:0003707 | steroid hormone receptor activity | - | IEA | Function |
| GO:0003713 | transcription coactivator activity | 8205615. | TAS | Function |
| GO:0004879 | nuclear receptor activity | 21873635. | IBA | Function |
| GO:0004879 | nuclear receptor activity | 23610160. | IDA | Function |
| GO:0005515 | protein binding | 10567391.14701856.16709599.17664281.21220346.22927646.23610160.25416956.25910212. | IPI | Function |
| GO:0005543 | phospholipid binding | 17664281. | IDA | Function |
| GO:0005634 | nucleus | 10567391.10848616.17664281. | IDA | Component |
| GO:0005654 | nucleoplasm | - | TAS | Component |
| GO:0006367 | transcription initiation from RNA polymerase II promoter | - | TAS | Process |
| GO:0007530 | sex determination | 24405868.27378692.27490115.27610946.27855412. | IMP | Process |
| GO:0007538 | primary sex determination | 9590178. | TAS | Process |
| GO:0008270 | zinc ion binding | - | IEA | Function |
| GO:0008584 | male gonad development | 10369247.27378692. | IMP | Process |
| GO:0008585 | female gonad development | 27378692. | IMP | Process |
| GO:0009755 | hormone-mediated signaling pathway | 21873635. | IBA | Process |
| GO:0009888 | tissue development | 21873635. | IBA | Process |
| GO:0010259 | multicellular organism aging | - | IEA | Process |
| GO:0010628 | positive regulation of gene expression | 27378692. | IDA | Process |
| GO:0010628 | positive regulation of gene expression | 23610160. | IMP | Process |
| GO:0019899 | enzyme binding | 17664281. | IPI | Function |
| GO:0030154 | cell differentiation | - | IEA | Process |
| GO:0030238 | male sex determination | 10369247. | IMP | Process |
| GO:0030325 | adrenal gland development | - | IEA | Process |
| GO:0030522 | intracellular receptor signaling pathway | - | IEA | Process |
| GO:0042445 | hormone metabolic process | - | IEA | Process |
| GO:0043401 | steroid hormone mediated signaling pathway | - | IEA | Process |
| GO:0043565 | sequence-specific DNA binding | 27378692. | IDA | Function |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 21873635. | IBA | Process |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 23610160. | IGI | Process |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | 17664281. | IMP | Process |
| GO:0045944 | positive regulation of transcription by RNA polymerase II | - | ISS | Process |
| GO:0050810 | regulation of steroid biosynthetic process | 10567391. | TAS | Process |
| GO:0051457 | maintenance of protein location in nucleus | - | IEA | Process |
| GO:0090575 | RNA polymerase II transcription factor complex | 21873635. | IBA | Component |
| GO:0090575 | RNA polymerase II transcription factor complex | - | ISS | Component |
| GO:0097210 | response to gonadotropin-releasing hormone | - | IEA | Process |
| GO:0097720 | calcineurin-mediated signaling | - | IEA | Process |
| GO:2000020 | positive regulation of male gonad development | 21412441. | IDA | Process |
| GO:2000195 | negative regulation of female gonad development | - | IEA | Process |